Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-01

Clinical Trial Update: Lapatinib and Trastuzumab With or Without Endocrine Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating lapatinib and trastuzumab with or without endocrine therapy in breast cancer; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lapatinib (Lapatinib)
  • Trastuzumab (trastuzumab)

Snippet

Sponsor: Baylor Breast Care Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-06-01